This is a routine filing. No immediate action is required by traders. Monitor for the actual meeting date and any subsequent voting results.
RPRX drugs
RPRX drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Apr 13 $48.43entry
- T+1 · 7mo ago +0.81%α −0.40% · $48.82
- T+5 · 7mo ago +1.80%α −1.50% · $49.30
- T+20 · 6mo ago +6.65%α −1.08% · $51.65
- T+60 · 4mo ago +20.52%α +11.60% · $58.37
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Royalty Pharma plc has filed a definitive proxy statement (DEFA14A) for an upcoming shareholder meeting. The filing is routine and does not indicate any activist campaign or contested vote. It is a standard annual disclosure required by the SEC.
Key Financial Metrics
Key Facts
- Company: Royalty Pharma plc (RPRX)
- Filing Type: DEFA14A (Definitive Proxy Statement)
- Purpose: Routine annual shareholder meeting
- No activist involvement or contested votes
- No new financial information disclosed
Financial Impact
No immediate financial impact
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001140361-26-014241 |
| Document: 0001140361-26-014241-index-headers.html | 0001140361-26-014241 |
| Document: 0001140361-26-014241-index.html | 0001140361-26-014241 |
| Document: 0001140361-26-014241.txt | 0001140361-26-014241 |
Track record
23 reports on RPRX
5 of 5 bullish or bearish reports moved the stock their way by T+5. Best: +15.20% at T+60 after the May 6, 2026 report. 5 of 5 went positive at some point.
Filters
- Nov 16, 2026today 144 Neutral 2/10 Entry price pending
- Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $67.57 to $68.97 Now $68.53 +1.41% ▲ +2.07% −1.22% vs SPY
- Nov 4, 202612d ago 8-K Neutral 5/10 No price data
- Nov 4, 202612d ago Press Release Bullish 6/10 Entry $67.56 to $70.01 Now $68.53 +1.43% ▲ +3.63% +4.54% vs SPY
- Sep 30, 20266w ago Insider Cluster Bearish 5/10 Entry $57.63 to $56.21 Now $68.53 −18.91% ▲ +2.46% +3.77% vs SPY
- Sep 4, 202610w ago Press Release Bearish 5/10 Entry $60.59 to $58.47 Now $68.53 −13.10% ▲ +3.50% +2.38% vs SPY
- Aug 19, 202612w ago Insider Cluster Neutral 3/10 Entry $60.57 to $61.92 Now $68.53 +13.14% ▲ +2.24% +1.12% vs SPY
- Aug 12, 202613w ago 144 Neutral 3/10 Entry $58.56 to $60.58 Now $68.53 +17.02% ▲ +3.45% +5.41% vs SPY
- Aug 5, 202614w ago 8-K Bullish 6/10 Entry $57.75 to $59.22 Now $68.53 +18.66% ▲ +2.55% +2.19% vs SPY
- Jul 2, 202619w ago Insider Cluster Neutral 2/10 Entry $57.77 to $57.96 Now $68.53 +18.62% ▲ +0.33% −0.60% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers